Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
03/08/1994 | US5292906 Tricyclic steroid analogs |
03/08/1994 | US5292753 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds |
03/03/1994 | WO1994004704A1 Effects of actin filaments on fibrin clot structure and lysis |
03/03/1994 | WO1994004536A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
03/03/1994 | WO1994004518A1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors |
03/03/1994 | WO1994004503A1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
03/03/1994 | WO1994004495A1 Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension |
03/03/1994 | WO1994004157A1 Transdermal application agent containing 3-keto-desogestrel |
03/03/1994 | WO1994004120A2 Methods of treating sexual dysfunction in animals with and h agonist |
03/03/1994 | WO1993023035A3 Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease |
03/03/1994 | CA2142875A1 The use of h2 and h3 agonists to treat sexual dysfunction |
03/03/1994 | CA2141690A1 Transdermal application agent containing 3-keto-desogestrel |
03/03/1994 | CA2138521A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
03/03/1994 | CA2138518A1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
03/03/1994 | CA2136842A1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors |
03/02/1994 | EP0585206A1 Tryptamines for treatment of circadian rhythm disorders |
03/02/1994 | EP0585058A1 Pharmaceutical compositions containing fatty acids and heparin |
03/02/1994 | EP0585057A1 Lithium salts of fatty acids for the treatment of viral infections and cancer |
03/02/1994 | EP0585027A1 Use of fatty acids for treating abnormal tissue calcification |
03/02/1994 | EP0584347A1 Enantiomeric hydroxylated xanthine compounds |
03/02/1994 | EP0584290A1 Endothelin antagonists |
03/02/1994 | EP0584159A1 Nutrient preparation. |
03/02/1994 | CN1083070A Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses |
03/01/1994 | US5290561 Patch of room temperature vulcanizable organopolysiloxane rubber, albuterol, diffusion enhancer of normal hydrocarbon alcohol |
03/01/1994 | CA1327359C Prostaglandin el derivatives as pharmacologically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration |
03/01/1994 | CA1327310C Process for enhancing milk yield in mammals and/or increasing the birth weight of their newborns and postnatal growth |
02/26/1994 | CA2104764A1 Method for the safe administration of fatty acids |
02/26/1994 | CA2104747A1 Method for the safe administration of fatty acids |
02/23/1994 | EP0583421A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
02/23/1994 | EP0583408A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
02/22/1994 | US5288717 Alkali metal salt of 8,9-dehydroestrone intermediate |
02/22/1994 | CA2104566A1 Fatty acid treatment |
02/17/1994 | WO1994003481A1 Diamino acid derivatives as antihypertensives |
02/17/1994 | WO1994003444A1 Amide derivatives |
02/17/1994 | WO1994003192A1 Composition comprising fertilized shell eggs |
02/17/1994 | CA2141810A1 Amide derivatives |
02/17/1994 | CA2141785A1 Diamino acid derivatives as antihypertensives |
02/17/1994 | CA2141197A1 Composition comprising fertilized shell eggs |
02/16/1994 | CN1023758C Antibiotic A 10255 complex and factors, process, microorganisms, and production thereof |
02/15/1994 | US5286753 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and pharmaceutical compositions thereof |
02/15/1994 | US5286734 Prevention or treatment of sexual dysfunction in male mammals |
02/15/1994 | CA1326998C Veterinary treatment |
02/09/1994 | EP0582502A1 Transdermal composition containing alfuzosin |
02/09/1994 | EP0581967A1 Protein with novel pharmacological characteristic |
02/09/1994 | CN1081615A Use of hydriodic acid as an aphrodisiac |
02/08/1994 | US5284873 Treatment of benign hypertrophy of the prostate |
02/08/1994 | US5284870 Aldose reductase inhibitor |
02/08/1994 | US5284849 Renin inhibitors |
02/04/1994 | CA2101357A1 Veterinary method |
02/03/1994 | WO1994002511A1 Calcium channel blocking polypeptide from agelenopsis aperta |
02/03/1994 | WO1994002493A1 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity |
02/03/1994 | WO1994002474A1 Endothelin receptor antagonists |
02/03/1994 | WO1994002465A1 INHIBITORS OF c-AMP PHOSPHODIESTERASE AND TNF |
02/03/1994 | WO1994002182A1 A two component fibrin-glue composition for improving in vitro fertilization |
02/03/1994 | WO1994002148A1 Novel bioactive compositions, preparation and use thereof |
02/03/1994 | WO1994002018A1 Peptides capable of controlling acrosome reaction |
02/03/1994 | WO1993010741A3 Sex steroid activity inhibitors |
02/03/1994 | CA2140630A1 Novel bioactive compositions, preparation and use thereof |
02/03/1994 | CA2140427A1 A two component fibrin-glue composition for improving in vitro fertilization |
02/03/1994 | CA2120014A1 Peptides capable of controlling acrosome reaction |
02/02/1994 | EP0581167A1 Novel arylglycinamide derivatives and preparative processes therefor and their use for treatment of dysuria |
02/02/1994 | EP0580774A1 Vitamin d derivatives comprising a lateral chain expoxide group |
02/02/1994 | EP0580609A1 Pharmaceutical xanthone derivatives |
02/01/1994 | US5283254 2-(imidazol-1-yl)-2-benzylethyldiene-aminoxyalkanoic acid derivatives |
02/01/1994 | US5283240 Administering prostaglandin antagonists |
02/01/1994 | CA1326680C N-acyl-n-naphthoylglycines as aldose reductase inhibitors |
01/26/1994 | EP0580459A1 Substituted Phenylimidazolidins, process for their preparation, their use as medicaments and their pharmaceutical compositions containing them |
01/26/1994 | EP0580429A1 Use of competitive NMDA receptor antagonists in the treatment of urinary incontinence |
01/26/1994 | EP0580185A1 Medicaments |
01/26/1994 | EP0579819A1 Novel pyridone derivatives, preparation method therefor, novel intermediates thereby obtained, their use as drugs, and pharmaceutical compositions containing same |
01/26/1994 | EP0470117B1 Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions |
01/26/1994 | CN1081182A New substituted phenylimidazolidines, their preparation process, their use as medicaments and the pharmaceutical compositions containing them |
01/26/1994 | CA2140916A1 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity |
01/25/1994 | WO1994002103A2 Ovulation inhibitor for hormonal contraception |
01/25/1994 | US5281624 Neurological disorders associated with norepinephrine imbalance |
01/25/1994 | US5281423 Administering to human females a syrup comprising hydriotic acid, water, and dextrose |
01/25/1994 | CA2140011A1 Ovulation inhibiting agent for hormonal contraception |
01/25/1994 | CA2100950A1 Use of competitive nmda receptor antagonists in the treatment of urinary incontinence |
01/25/1994 | CA1326485C Thioformamide derivatives |
01/20/1994 | WO1994001100A1 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY |
01/19/1994 | EP0579496A1 4-Aminoquinazoline derivatives, and their use as medicine |
01/19/1994 | EP0579488A1 Composition for treating mastitis and metritis |
01/19/1994 | EP0579304A1 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
01/19/1994 | EP0579223A1 Carboxylic acid derivatives having 5 alpha-reductase inhibitory activity |
01/19/1994 | EP0579169A1 Alkylenediamine derivatives |
01/19/1994 | EP0578643A1 Compound and pharmaceutical composition for treatment of calcium oxalate stone disease |
01/19/1994 | CN1080931A Calcium channel blocking polypeptides from filistata hibernalis |
01/18/1994 | US5280035 Cycloalkylene azoles and their use as aromatase inhibitors |
01/18/1994 | US5280033 Substituted 1-(alkoxy-iminoalkyl) imidazole derivatives and their use in treating disease related to an enhancement of thromboxane-A2 syntheis |
01/18/1994 | US5280023 Containing a mixture of estrogen and gestagen |
01/18/1994 | CA2100642A1 Carboxylic acid derivatives |
01/18/1994 | CA1326234C 17.beta.-(cyclopropylamino)androst-5-en-3.beta.-ol and related compoundsuseful as_c__-__ lyase inhibitors |
01/16/1994 | CA2100626A1 4-aminoquinazoline derivatives |
01/15/1994 | CA2100376A1 Alkylenediamine derivatives |
01/12/1994 | EP0578521A1 New peptide derivatives with bradykinin-antagonistic activity, process to prepare them and pharmaceutical compositions containing them |
01/12/1994 | EP0578516A1 Optionally substituted phenylimidazolidins, process for their preparation, their use as medicaments and the pharmaceutical compositions containing them |
01/12/1994 | EP0578293A1 E-coli P-fimbrine as immunogenic carrier system against GnRH |
01/12/1994 | EP0577957A1 8-Chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
01/12/1994 | EP0577602A1 Transdermal contraceptive formulations, methods and devices |
01/12/1994 | EP0484429B1 Method of treating infertility or sub-fertility in adult men, and the use of preparations in the method. |